Picture of iSpecimen logo

ISPC — iSpecimen News Story

0.000.00%
us flag iconLast trade - 00:00
TechnologySpeculativeMicro CapSucker Stock

iSpecimen Inc reports results for the quarter ended in September - Earnings Summary

* iSpecimen Inc  ISPC.OQ  reported a quarterly adjusted loss
of 35
cents​​ per share for the quarter ended in September. The mean
expectation of two analysts for the quarter was for a loss of 34
cents per share.
    * Revenue was $2.58 million​; analysts expected $2.45
million. 
    * iSpecimen Inc's reported EPS for the quarter was a loss
of 35
cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * iSpecimen Inc shares had fallen by 1.8% this quarter and
lost 79.3% so far this year.
    * The company reported a quarterly loss of $3.1 million.
    * Wall Street's median 12-month price target for iSpecimen
Inc is
$10.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
8 at 02:32 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.34          -0.35          Missed
 Jun. 30 2022      -0.27          -0.30          Missed
 Mar. 31 2022      -0.25          -0.27          Missed
 Dec. 31 2021      -0.22

Recent news on iSpecimen

See all news